Screening for Malnutrition in Obese Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHAN University of Applied Sciences
About this trial
More than half of the Dutch population is overweight or obese, which is associated with an increased risk of COVID-19 and worse outcomes during a COVID-19 infection. In addition, malnutrition and loss of muscle mass are often reported with COVID-19, as well as with cancer and other diseases. Malnutrition and overweight or obesity can coexist, even within the same individual. It is still unclear which mechanisms contribute to the worse outcomes of COVID-19 and other diseases in case of overweight, malnutrition, and a combination of both. The aim of this study is to identify which parameters are associated with worse disease outcomes through literature research and database research (COVID-19 and cancer, more than 150.000 participants). In addition, a clinical study will be conducted aiming to develop a simple screening tool for the recognition of the coexistence of malnutrition and overweight or obesity in clinical practice.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age 18 years or older
Overweight (BMI of 25 kg/m² or higher)
Disqualifiers
Physically or mentally unable to participate.
Severe cognitive disorder or severe emotional instability, as assessed by the attending nurse or physician.
Insufficient proficiency in the Dutch language to express themselves properly and no interpreter or assistant to help.
Patient resides in a nursing or care home.
Trial population
Hospital in- and outpatients with overweight or obesity
Trial design
Design model
Other
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
2,000 Participants
are grouped into 1 trial groupGroup A: Patients with overweight or obesity
Trial outcomes
Primary outcomes
1
Malnutrition
Malnutrition will be assessed by a working definition based on the GLIM-criteria and a Delphi-study
Time frame
9 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
HAN University of Applied Sciences
Lead sponsor
Amsterdam University of Applied Sciences
Collaborator
National Institute for Public Health and the Environment (RIVM)
Collaborator
Erasmus Medical Center
Collaborator
Wageningen University and Research
Collaborator
Gelderse Vallei Hospital
Collaborator
Amsterdam UMC, location VUmc
Collaborator
Amsterdam UMC, location AMC
Collaborator
Source ClinicalTrials.gov